Cellular uptake and efflux of palbociclib in vitro in single cell and spheroid models
Yes === Adequate drug distribution through tumours is essential for treatment to be effective. Palbociclib is a cyclin-dependent kinase (CDK) 4/6 inhibitor approved for use in patients with hormone receptor (HR) positive, HER2 negative metastatic breast cancer (BC). It has unusual physicochemical pr...
Main Authors: | , , , , , , , , , |
---|---|
Language: | en |
Published: |
2019
|
Subjects: | |
Online Access: | http://hdl.handle.net/10454/17174 |